![]() |
Name |
[4-(Hydroxymethyl)-4,4a,8,8a-tetrahydro-[1,3]dioxino[5,4-d][1,3]dioxin-8-yl]methanol
|
Molecular Formula | C8H14O6 | |
IUPAC Name* |
[4-(hydroxymethyl)-4,4a,8,8a-tetrahydro-[1,3]dioxino[5,4-d][1,3]dioxin-8-yl]methanol
|
|
SMILES |
C1OC(C2C(O1)C(OCO2)CO)CO
|
|
InChI |
InChI=1S/C8H14O6/c9-1-5-7-8(14-3-11-5)6(2-10)12-4-13-7/h5-10H,1-4H2
|
|
InChIKey |
DLIMVTKZIGEWCB-UHFFFAOYSA-N
|
|
Synonyms |
1,3,5,7-Tetraoxadecalin 4,8-dimethanol; 5334-20-3; MLS002637570; [4-(hydroxymethyl)-4,4a,8,8a-tetrahydro-[1,3]dioxino[5,4-d][1,3]dioxin-8-yl]methanol; 6945-65-9; 2,4:3,5-DI-O-METHYLENE-L-IDITOL; NSC1388; CHEMBL1885909; 2,4:3,5-Dimethylene-l-iditol; DTXSID80277258; NSC-1388; NSC52137; NSC-52137; 2,5-DI-O-METHYLENE-L-IDITOL; SMR001547101; FT-0667431
|
|
CAS | 6945-65-9 | |
PubChem CID | 219727 | |
ChEMBL ID | CHEMBL1885909 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 206.19 | ALogp: | -1.7 |
HBD: | 2 | HBA: | 6 |
Rotatable Bonds: | 2 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 77.4 | Aromatic Rings: | 2 |
Heavy Atoms: | 14 | QED Weighted: | 0.604 |
Caco-2 Permeability: | -5.283 | MDCK Permeability: | 0.00038825 |
Pgp-inhibitor: | 0 | Pgp-substrate: | 0.002 |
Human Intestinal Absorption (HIA): | 0.272 | 20% Bioavailability (F20%): | 0.505 |
30% Bioavailability (F30%): | 0.028 |
Blood-Brain-Barrier Penetration (BBB): | 0.248 | Plasma Protein Binding (PPB): | 10.49% |
Volume Distribution (VD): | 0.434 | Fu: | 82.19% |
CYP1A2-inhibitor: | 0.015 | CYP1A2-substrate: | 0.721 |
CYP2C19-inhibitor: | 0.012 | CYP2C19-substrate: | 0.235 |
CYP2C9-inhibitor: | 0.002 | CYP2C9-substrate: | 0.025 |
CYP2D6-inhibitor: | 0.002 | CYP2D6-substrate: | 0.121 |
CYP3A4-inhibitor: | 0.008 | CYP3A4-substrate: | 0.124 |
Clearance (CL): | 1.809 | Half-life (T1/2): | 0.71 |
hERG Blockers: | 0.032 | Human Hepatotoxicity (H-HT): | 0.114 |
Drug-inuced Liver Injury (DILI): | 0.451 | AMES Toxicity: | 0.357 |
Rat Oral Acute Toxicity: | 0.154 | Maximum Recommended Daily Dose: | 0.007 |
Skin Sensitization: | 0.147 | Carcinogencity: | 0.116 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.185 |
Respiratory Toxicity: | 0.009 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000447 | ![]() |
0.259 | D0Z4EI | ![]() |
0.232 | ||
ENC001221 | ![]() |
0.211 | D0T5BC | ![]() |
0.214 | ||
ENC000944 | ![]() |
0.208 | D0YS7D | ![]() |
0.206 | ||
ENC000661 | ![]() |
0.203 | D0H2RI | ![]() |
0.203 | ||
ENC001062 | ![]() |
0.203 | D0H3KI | ![]() |
0.203 | ||
ENC003068 | ![]() |
0.203 | D07NSU | ![]() |
0.203 | ||
ENC001312 | ![]() |
0.200 | D0D0ZD | ![]() |
0.185 | ||
ENC003488 | ![]() |
0.197 | D05ZYM | ![]() |
0.179 | ||
ENC003056 | ![]() |
0.193 | D01JQJ | ![]() |
0.175 | ||
ENC001986 | ![]() |
0.192 | D0T3AD | ![]() |
0.175 |